<bill session="117" type="s" number="1132" updated="2023-01-11T13:49:21Z">
  <state datetime="2021-04-15">REFERRED</state>
  <status>
    <introduced datetime="2021-04-15"/>
  </status>
  <introduced datetime="2021-04-15"/>
  <titles>
    <title type="display">EPI Act</title>
    <title type="official" as="introduced">A bill to establish a cap on out-of-pocket costs for insulin.</title>
    <title type="short" as="introduced">Ending Pricey Insulin Act</title>
    <title type="short" as="introduced">EPI Act</title>
  </titles>
  <sponsor bioguide_id="K000393"/>
  <cosponsors/>
  <actions>
    <action datetime="2021-04-15">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-04-15" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Child health"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Employee benefits and pensions"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Inflation and prices"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Military medicine"/>
    <term name="Military personnel and dependents"/>
    <term name="Poverty and welfare assistance"/>
    <term name="Prescription drugs"/>
    <term name="Veterans' medical care"/>
  </subjects>
  <amendments/>
  <summary date="2021-11-20T20:09:48Z" status="Introduced in Senate">Ending Pricey Insulin Act or the EPI Act

This bill establishes a maximum out-of-pocket cost of $50 for a 30-day supply of insulin.

Specifically, no private or public health insurance plan may charge an enrollee more than $50 for a 30-day supply of insulin, regardless of the amount of insulin prescribed for that period. This includes any deductible, co-payment, coinsurance, or other cost-sharing requirement.

This $50 limit also applies to the cash price for insulin prescriptions for uninsured individuals.

The requirements of this bill apply beginning on January 1, 2022, irrespective of the date this bill is enacted.</summary>
</bill>
